Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
Immunogenic cell death (ICD) is a distinct type of stress-induced regulated cell death that can lead to adaptive immune responses and the establishment of immunological memory. ICD exhibits both similarities and differences when compared to apoptosis and other non-apoptotic forms of regulated cell d...
Saved in:
| Main Authors: | Lei Dou, Yu Fang, Huiyuan Yang, Guo Ai, Na Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2437918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticles induced cuproptosis to enhance antitumor immunotherapy
by: Wen Deng, et al.
Published: (2025-07-01) -
Concurrent induction of pyroptosis and immunogenic cell death by capsaicin/graphene nanocomplex for enhanced breast cancer immunotherapy
by: Silu Li, et al.
Published: (2025-05-01) -
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
by: Guojuan Sun, et al.
Published: (2025-01-01) -
Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma
by: Meng Zhang, et al.
Published: (2025-02-01) -
Immunogenic Cell Death and Metabolic Reprogramming in Cancer: Mechanisms, Synergies, and Innovative Therapeutic Strategies
by: Jie Jiang, et al.
Published: (2025-04-01)